420 related articles for article (PubMed ID: 17991443)
1. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
Regina Todeschini A; Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):421-33. PubMed ID: 17991443
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
3. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility.
Hakomori SI
FEBS Lett; 2010 May; 584(9):1901-6. PubMed ID: 19874824
[TBL] [Abstract][Full Text] [Related]
4. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
5. The glycosynapse.
Hakomori Si SI
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):225-32. PubMed ID: 11773621
[TBL] [Abstract][Full Text] [Related]
6. GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation.
Santos RCM; Lucena DMS; Loponte HFBR; Alisson-Silva F; Dias WB; Lins RD; Todeschini AR
Glycoconj J; 2022 Oct; 39(5):653-661. PubMed ID: 35536494
[TBL] [Abstract][Full Text] [Related]
7. Glycosynapses: microdomains controlling carbohydrate-dependent cell adhesion and signaling.
Hakomori S
An Acad Bras Cienc; 2004 Sep; 76(3):553-72. PubMed ID: 15334254
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization.
Hakomori S
Glycoconj J; 2004; 21(3-4):125-37. PubMed ID: 15483378
[TBL] [Abstract][Full Text] [Related]
10. Gangliosides play an important role in the organization of CD82-enriched microdomains.
Odintsova E; Butters TD; Monti E; Sprong H; van Meer G; Berditchevski F
Biochem J; 2006 Dec; 400(2):315-25. PubMed ID: 16859490
[TBL] [Abstract][Full Text] [Related]
11. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
12. GM3 and cancer.
Hakomori SI; Handa K
Glycoconj J; 2015 Feb; 32(1-2):1-8. PubMed ID: 25613425
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends.
Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):325-46. PubMed ID: 17976918
[TBL] [Abstract][Full Text] [Related]
14. Shed gangliosides provide detergent-independent evidence for type-3 glycosynapses.
Thorne RF; Mhaidat NM; Ralston KJ; Burns GF
Biochem Biophys Res Commun; 2007 Apr; 356(1):306-11. PubMed ID: 17350595
[TBL] [Abstract][Full Text] [Related]
15. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2005 Apr; 280(16):16227-34. PubMed ID: 15710618
[TBL] [Abstract][Full Text] [Related]
16. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides and beta1-integrin are required for caveolae and membrane domains.
Singh RD; Marks DL; Holicky EL; Wheatley CL; Kaptzan T; Sato SB; Kobayashi T; Ling K; Pagano RE
Traffic; 2010 Mar; 11(3):348-60. PubMed ID: 20051050
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate to carbohydrate interaction in development process and cancer progression.
Handa K; Hakomori SI
Glycoconj J; 2012 Dec; 29(8-9):627-37. PubMed ID: 22610315
[TBL] [Abstract][Full Text] [Related]
19. CD82 and Gangliosides Tune CD81 Membrane Behavior.
Fernandez L; Malrieu M; Bénistant C; Dosset P; Rubinstein E; Odintsova E; Berditchevski F; Milhiet PE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445169
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
